Chitosan-hyaluronic acid nanoparticles for gene silencing: The role of hyaluronic acid on the nanoparticles' formation and activity

Colloids and Surfaces B: Biointerfaces

Volumn 103, Issue , 2013, Pages 615-623

  Al Qadi, Sonia ^a   Alatorre Meda, Manuel ^a   Zaghloul, Eman M ^b,c   Taboada, Pablo ^a   Remunán López, Carmen ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Alexandria University Faculty of Pharmacy   (Egypt)

Author keywords

A549 Luc cells; Chitosan nanoparticles; Gene silencing; Hyaluronic acid; Isothermal titration calorimetry

Indexed keywords

BINDING STRENGTH; CELL VIABILITY; CHITOSAN NANOPARTICLES; GENE DELIVERY SYSTEMS; GENE SILENCING; HYALURONIC ACIDS; IONOTROPIC GELATION; ISOTHERMAL TITRATION CALORIMETRY; LIPOFECTAMINE; PHYSICOCHEMICAL PROPERTY;

BIOCOMPATIBILITY; CALORIMETERS; CALORIMETRY; CELLS; CHITOSAN; CYTOLOGY; GELATION; GENE TRANSFER; GENES; ISOTHERMS; LIPOSOMES; NANOPARTICLES; TITRATION;

ORGANIC ACIDS;

CHITOSAN; HYALURONIC ACID; LIPOFECTAMINE; LUCIFERASE; NANOPARTICLE; SMALL INTERFERING RNA;

ANEMOMETRY; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; BIOLOGICAL ACTIVITY; CELL ASSAY; CELL PROLIFERATION; CELL VIABILITY; GELATION; GENE SILENCING; HUMAN; HUMAN CELL; ISOTHERMAL TITRATION CALORIMETRY; LIGHT SCATTERING; MOLECULAR INTERACTION; MOLECULAR WEIGHT; NANOFABRICATION; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; STABLE EXPRESSION; STRUCTURE ANALYSIS; THERMODYNAMICS; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

CELL LINE, TUMOR; CELL SURVIVAL; CHITOSAN; GENE SILENCING; HUMANS; HYALURONIC ACID; LUCIFERASES; NANOPARTICLES; PARTICLE SIZE; RNA, SMALL INTERFERING; STATIC ELECTRICITY; THERMODYNAMICS; TRANSFECTION;

EID: 84871663410     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2012.11.009     Document Type: Article

References (50)

1. Castanotto D., Rossi J.J. The promises and pitfalls of RNA-interference-based therapeutics. Nature 2009, 457:426-433.
2. Juliano R., Alam M.R., Dixit V., Kang H. Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides. Nucleic Acids Res. 2008, 36:4158-4171.
3. M. Alatorre-Meda, E. Rodríguez-Velázquez, J.R. Rodriguez, Polycation-Mediated Gene Delivery: The Physicochemical Aspects Governing the Process, in: X. Yuan (Ed.), Non-Viral Gene Therapy, InTech, 2011, Available from: http://www.intechopen.com/articles/show/title/polycation-mediated-gene-delivery-the-physicochemical-aspects-governing-the-process.
4. Tros de Ilarduya C., Sun Y., Duezguenes N. Gene delivery by lipoplexes and polyplexes. Eur. J. Pharm. Sci. 2010, 40:159-170.
5. Agnihotri S.A., Mallikarjuna N.N., Aminabhavi T.M. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J. Control. Release 2004, 100:5-28.
6. Rudzinski W.E., Aminabhavi T.M. Chitosan as a carrier for targeted delivery of small interfering RNA. Int. J. Pharm. 2010, 399:1-11.
7. Aktas Y., Andrieux K., Alonso M.J., Calvo P., Gursoy R.N., Couvreur P., Capan Y. Preparation and in vitro evaluation of chitosan nanoparticles containing a caspase inhibitor. Int. J. Pharm. 2005, 298:378-383.
8. Fernandez-Urrusuno R., Calvo P., Remunan-Lopez C., Vila-Jato J.L., Alonso M.J. Enhancement of nasal absorption of insulin using chitosan nanoparticles. Pharm. Res. 1999, 16:1576-1581.
9. Fernandez-Urrusuno R., Romani D., Calvo P., Vila-Jato J.L., Alonso M.J. Development of a freeze-dried formulation of insulin-loaded chitosan nanoparticles intended for nasal administration. STP Pharma Sci. 1999, 9:429-436.
10. Al-Qadi S., Grenha A., Carrión-Recio D., Seijo B., Remuñán-López C. Microencapsulated chitosan nanoparticles for pulmonary protein delivery: in vivo evaluation of insulin-loaded formulations. J. Control. Release 2011.
11. Al-Qadi S., Grenha A., Remunan-Lopez C. Microspheres loaded with polysaccharide nanoparticles for pulmonary delivery: preparation, structure and surface analysis. Carbohydr. Polym. 2011, 86:25-34.
12. Ito T., Iida-Tanaka N., Koyama Y. Efficient in vivo gene transfection by stable DNA/PEI complexes coated by hyaluronic acid. J. Drug Target. 2008, 16:276-281.
13. Menzel E.J., Farr C. Hyaluronidase and its substrate hyaluronan: biochemistry, biological activities and therapeutic uses. Cancer Lett. 1998, 131:3-11.
14. Manna U., Bharani S., Patil S. Layer-by-layer self-assembly of modified hyaluronic acid/chitosan based on hydrogen bonding. Biomacromolecules 2009, 10:2632-2639.
15. Luo Y., Prestwich G.D. Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate. Bioconjugate Chem. 1999, 10:755-763.
16. Contreras-Ruiz L., de la Fuente M., Garcia-Vazquez C., Saez V., Seijo B., Alonso M.J., Calonge M., Diebold Y. Ocular tolerance to a topical formulation of hyaluronic acid and chitosan-based nanoparticles. Cornea 2010, 29:550-558.
17. Oyarzun-Ampuero F.A., Brea J., Loza M.I., Torres D., Alonso M.J. Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma. Int. J. Pharm. 2009, 381:122-129.
18. de la Fuente M., Seijo B., Alonso M.J. Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy. Invest. Ophthalmol. Vis. Sci. 2008, 49:2016-2024.
19. Ito T., Iida-Tanaka N., Niidome T., Kawano T., Kubo K., Yoshikawa K., Sato T., Yang Z., Koyama Y. Hyaluronic acid and its derivative as a multi-functional gene expression enhancer: protection from non-specific interactions, adhesion to targeted cells, and transcriptional activation. J. Control. Release 2006, 112:382-388.
20. Mok H., Park J.W., Park T.G. Antisense oligodeoxynucleotide-conjugated hyaluronic acid/protamine nanocomplexes for intracellular gene inhibition. Bioconjugate Chem. 2007, 18:1483-1489.
21. Collis L., Hall C., Lange L., Ziebell M., Prestwich R., Turley E.A. Rapid hyaluronan uptake is associated with enhanced motility: implications for an intracellular mode of action. FEBS Lett. 1998, 440:444-449.
22. Evanko S.P., Wight T.N. Intracellular localization of hyaluronan in proliferating cells. J. Histochem. Cytochem. 1999, 47:1331-1341.
23. Ruponen M., Ronkko S., Honkakoski P., Pelkonen J., Tammi M., Urtti A. Extracellular glycosaminoglycans modify cellular trafficking of lipoplexes and polyplexes. J. Biol. Chem. 2001, 276:33875-33880.
24. Goycoolea F.M., Lollo G., Remuñan López C., Quaglia F., Alonso M.J. Chitosan-alginate blended nanoparticles as carriers for the transmucosal delivery of macromolecules. Biomacromolecules 2009, 10:1736-1743.
25. Tahara K., Yamamoto H., Hirashima N., Kawashima Y. Chitosan-modified poly(d,l-lactide-co-glycolide) nanospheres for improving siRNA delivery and gene-silencing effects. Eur. J. Pharm. Biopharm. 2010, 74:421-426.
26. Alatorre-Meda M., Taboada P., Sabin J., Krajewska B., Varela L.M., Rodriguez J.R. DNA-chitosan complexation: a dynamic light scattering study. Colloids Surf. A: Physicochem. Eng. Aspects 2009, 339:145-152.
27. Alatorre-Meda M., Gonzalez-Perez A., Rodriguez J.R. DNA-METAFECTENE (TM) PRO complexation: a physical chemistry study. Phys. Chem. Chem. Phys. 2010, 12:7464-7472.
28. Kim W., Yamasaki Y., Kataoka K. Development of a fitting model suitable for the isothermal titration calorimetric curve of DNA with cationic ligands. J. Phys. Chem. B 2006, 110:10919-10925.
29. Berger J., Reist M., Mayer J.M., Felt O., Peppas N.A., Gurny R. Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications. Eur. J. Pharm. Biopharm. 2004, 57:19-34.
30. Malhotra M., Kulamarva A., Sebak S., Paul A., Bhathena J., Mirzaei M., Prakash S. Ultrafine chitosan nanoparticles as an efficient nucleic acid delivery system targeting neuronal cells. Drug Dev. Ind. Pharm. 2009, 35:719-726.
31. Rojanarata T., Opanasopit P., Techaarpornkul S., Ngawhirunpat T., Ruktanonchai U. Chitosan-thiamine pyrophosphate as a novel carrier for siRNA delivery. Pharm. Res. 2008, 25:2807-2814.
32. Chithrani B.D., Chan W.C.W. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett. 2007, 7:1542-1550.
33. Merkel O.M., Mintzer M.A., Librizzi D., Samsonova O., Dicke T., Sproat B., Garn H., Barth P.J., Simanek E.E., Kissel T., Triazine Dendrimers as nonviral vectors for in vitro and in vivo RNAi: the effects of peripheral groups and core structure on biological activity. Mol. Pharm. 2010, 7:969-983.
34. Schmitt C., Moitzi C., Bovay C., Rouvet M., Bovetto L., Donato L., Leser M.E., Schurtenberger P., Stradner A. Internal structure and colloidal behaviour of covalent whey protein microgels obtained by heat treatment. Soft Matter 2010, 6:4876-4884.
35. Kabanov A.V., Kabanov V.A. Interpolyelectrolyte and block ionomer complexes for gene delivery: physico-chemical aspects. Adv. Drug Deliv. Rev. 1998, 30:49-60.
36. Dias R.S., Pais A., Miguel M.G., Lindman B. Modeling of DNA compaction by polycations. J. Chem. Phys. 2003, 119:8150-8157.
37. Shu X.Z., Zhu K.J. Controlled drug release properties of ionically cross-linked chitosan beads: the influence of anion structure. Int. J. Pharm. 2002, 233:217-225.
38. Gupta K.C., Kumar M. Studies on semi-interpenetrating polymer network beads of chitosan-poly(ethylene glycol) for the controlled release of drugs. J. Appl. Polym. Sci. 2001, 80:639-649.
39. Shu X.Z., Zhu K.J. A novel approach to prepare tripolyphosphate/chitosan complex beads for controlled release drug delivery. Int. J. Pharm. 2000, 201:51-58.
40. Alatorre-Meda M., Taboada P., Hardl F., Wagner T., Freis M., Rodriguez J.R. The influence of chitosan valence on the complexation and transfection of DNA The weaker the DNA-chitosan binding the higher the transfection efficiency. Colloids Surf. B: Biointerfaces 2011, 82:54-62.
41. Schaffer D.V., Fidelman N.A., Dan N., Lauffenburger D.A. Vector unpacking as a potential barrier for receptor-mediated polyplex gene delivery. Biotechnol. Bioeng. 2000, 67:598-606.
42. Matulis D., Rouzina I., Bloomfield V.A. Thermodynamics of DNA binding and condensation: isothermal titration calorimetry and electrostatic mechanism. J. Mol. Biol. 2000, 296:1053-1063.
43. Turgeon S.L., Schmitt C., Sanchez C. Protein-polysaccharide complexes and coacervates. Curr. Opin. Colloid Interface Sci. 2007, 12:166-178.
44. Manning G.S., Ray J. Counterion condensation revisited. J. Biomol. Struct. Dyn. 1998, 16:461-476.
45. Alatorre-Meda M., Taboada P., Krajewska B., Willemeit M., Deml A., Klosel R., Rodriguez J.R. DNA-poly(diallyldimethylammonium chloride) complexation and transfection efficiency. J. Phys. Chem. B 2010, 114:9356-9366.
46. Carlstedt J., Gonzalez-Perez A., Alatorre-Meda M., Dias R.S., Lindman B. Release of DNA from surfactant complexes induced by 2-hydroxypropyl-beta-cyclodextrin. Int. J. Biol. Macromol. 2010, 46:153-158.
47. Zhou Y.L., Li Y.Z. The interaction of poly(ethylenimine) with nucleic acids and its use in determination of nucleic acids based on light scattering. Spectrochim. Acta. A. Mol. Biomol. Spectrosc. 2004, 60:377-384.
48. Milev S., Bosshard H.R., Jelesarov I. Enthalpic and entropic effects of salt and polyol osmolytes on site-specific protein-DNA association: the integrase Tn916-DNA complex. Biochemistry 2005, 44:285-293.
49. Freire E., Mayorga O.L., Straume M. Isothermal titration calorimetry. Anal. Chem. 1990, 62:A950-A959.
50. Nasti A., Zaki N.M., de Leonardis P., Ungphaiboon S., Sansongsak P., Rimoli M.G., Tirelli N. Chitosan/TPP and Chitosan/TPP-hyaluronic acid nanoparticles: systematic optimisation of the preparative process and preliminary biological evaluation. Pharm. Res. 2009, 26:1918-1930.